警訊藥品
一個藥品使用錯誤時，有極高機率會對病人造成明顯傷害，則稱此藥為高警訊藥品 ( high-alert medications )。本部比照美國ISMP ( Institute for Safe Medication Practices ) 公佈之高警訊藥品訂定本院之高警訊藥品品項，定期更新公告，提供全院醫療人員參考。
表. 美國ISMP定義高警訊藥品
| 應提高警覺之21類藥品 | 應提高警覺之12項特定藥品 | ||
|---|---|---|---|
| 1. | Adrenergic agonists, iv | 1. | EPINEPHrine |
| 2. | Adrenergic antagonists, iv | 2. | Subcutaneous epoprostenol (Flolan),IV |
| 3. | Anesthetic agents, general, inhaled & iv | 3. | Insulin U-500 (special emphasis) |
| 4. | Antiarrhythmics, iv | 4. | Magnesium sulfate injection |
| 5. | Antithrombotic agents, including warfarin, low-molecular-weight heparin, iv unfractionated heparin, factor Xa inhibitors, direct thrombin inhibitors, thrombolytics, and glycoprotein IIb/IIIa inhibitors |
5. | Methotrexate, oral, non-oncologic use |
| 6. | Opium tincture | ||
| 7. | Oxytocin, IV | ||
| 8. | Nitroprusside, sodium, for injection | ||
| 9. | Potassium chloride for injection | ||
| 10. | Concentrate potassium phosphates injection | ||
| 11 | Promethazine, IV | ||
| 6. | Cardioplegic solutions | 12. | Vasopressin, IV or intraosseous |
| 7. | Chemotherapeutic agents, parenteral & oral | ||
| 8. | Dextrose, hypertonic, 20% or greater | ||
| 9. | Dialysis solutions, peritoneal & hemodialysis | ||
| 10. | Epidural or intrathecal medications | ||
| 11. | Inotropic medications, iv | ||
| 12. | Insulin, subcutaneous and IV | ||
| 13. | Liposomal forms of drugs (e.g., liposomal amphotericin B) |
||
| 14. | Moderate sedation agents, IV | ||
| 15. | Moderate sedation agents, oral, for children | ||
| 16. | Narcotics/opiates, iv , transdermal & oral (including liquid concentrates, immediate- & sustained- release) | ||
| 17. | Neuromuscular blocking agents | ||
| 18. | Parenteral nutrition preparations | ||
| 19. | Radiocontrast agents, IV | ||
| 20. | Sterile water for injection, inhalation, and irrigation (excluding pour bottles) in containers of 100ml or more | ||
| 21. | Sodium chloride injection, hypertonic, more than 0.9% concentration | ||